Q: Currently I still have have a small profit in Topicus. Considering selling and replacing with Teradyne. Would you make this change?
5i Research Answer:
While we do not consider TOI as a SELL, we do think TER is better positioned today for gains. We would be comfortable with this switch if only one is to be owned.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in TER.